SandboxAQ Puts Drug Discovery AI Inside Claude

SandboxAQ Puts Drug Discovery AI Inside Claude

SandboxAQ just made its drug discovery models accessible inside Claude, no specialized computing background required. The average drug costs $2.6 billion to develop. That math is about to change for anyone paying attention. Here’s who wins and who gets left behind.

SandboxAQ Drug Discovery Models Now Live in Claude

SandboxAQ Drug Discovery Models Now Live in Claude

SandboxAQ has brought its Large Quantitative Models for molecular simulation into the Claude interface. Drug discovery that once required supercomputers and specialized teams now runs through a browser tab. Here’s what that actually means for pharma, biotech, and anyone paying attention.

SandboxAQ Drug Discovery Comes to Claude Without a PhD

SandboxAQ Drug Discovery Comes to Claude Without a PhD

SandboxAQ connected its drug discovery AI to Claude, putting simulation tools that once cost tens of thousands of dollars into any researcher’s browser. The science story is interesting. The money story is bigger. Here’s who wins and who loses.

Anthropic Now Has More Business Customers Than OpenAI

Anthropic Now Has More Business Customers Than OpenAI

Ramp spending data shows Anthropic now has more business customers than OpenAI in 2026. While everyone bet on the first mover, businesses quietly ran their own tests and switched. Here’s why it happened and what smart operators should do about it.

Medicare’s AI Payment Model Is a $900 Billion Gold Rush

Medicare's AI Payment Model Is a $900 Billion Gold Rush

Medicare has quietly built a payment system that rewards doctors for using AI tools, and the market sits at over $900 billion annually. With Anthropic chasing a $950 billion valuation and Owkin building biological AI agents, the money is moving fast. Most tech founders still haven’t noticed.